Single-donor islet transplantation and long-term insulin independence in select patients with type 1 diabetes mellitus

Transplantation

Volumn 98, Issue 9, 2014, Pages 1007-1012

  Al Adra, David P ^a   Gill, Richdeep S ^a   Imes, Sharleen ^a   O'Gorman, Doug ^a   Kin, Tatsuya ^a   Axford, Sara J ^b   Shi, Xinzhe ^c   Senior, Peter A ^d   James Shapiro, A M ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b ST GEORGE S UNIVERSITY   (Grenada)

^c ROYAL ALEXANDRA HOSPITAL   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Diabetes; Insulin independence; Islet transplantation; Single donor

Indexed keywords

HEPARIN; INSULIN; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CANADA; CELLULAR PARAMETERS; CONTROLLED STUDY; DONOR; DRUG INFUSION; FEMALE; GRAFT RECIPIENT; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PANCREAS ISLET TRANSPLANT MASS; PANCREAS ISLET TRANSPLANTATION; PATIENT SELECTION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TREATMENT DURATION; ANALYSIS; CYTOLOGY; DIABETES MELLITUS, TYPE 1; DISEASE FREE SURVIVAL; GLUCOSE BLOOD LEVEL; IMMUNOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PANCREAS ISLET; PROCEDURES; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 1; DISEASE-FREE SURVIVAL; FEMALE; HEPARIN; HUMANS; INSULIN; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 84925026849     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000217     Document Type: Article

References (22)

1. Shapiro AM. State of the art of clinical islet transplantation and novel protocols of immunosuppression. Curr Diab Rep 2011; 11: 345.
2. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230.
3. Thompson DM, MelocheM, Ao Z, etal. Reduced progression of diabetic microvascular complications with islet cell transplantation compared with intensive medical therapy. Transplantation 2011; 91: 373.
4. Warnock GL, Thompson DM, Meloche RM, et al. A multi-year analysis of islet transplantation compared with intensive medical therapy on progression of complications in type 1 diabetes. Transplantation 2008; 86: 1762.
5. Eich T, Eriksson O, Lundgren T, Nordic Network for Clinical Islet Transplantation. Visualization of early engraftment in clinical islet transplantation by positron-emission tomography. N Engl J Med 2007; 356: 2754.
6. Shapiro AM. Strategies toward single-donor islets of Langerhans transplantation. Curr Opin Organ Transplant 2011; 16: 627.
7. Naziruddin B, Wease S, Stablein D, et al. HLA class I sensitization in islet transplant recipients: report from the Collaborative Islet Transplant Registry. Cell Transplant 2012; 21: 901.
8. Hering BJ, Kandaswamy R, Ansite JD, et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 2005; 293: 830.
9. Hering BJ, Kandaswamy R, Harmon JV, et al. Transplantation of cultured islets from two-layer preserved pancreases in type 1 diabetes with anti-CD3 antibody. Am J Transplant 2004; 4: 390.
10. Loganathan G, Graham ML, Radosevich DM, et al. Factors affecting transplant outcomes in diabetic nude mice receiving human, porcine, and nonhuman primate islets: analysis of 335 transplantations. Transplantation 2013; 95: 1439.
11. Koh A, Senior P, Salam A, et al. Insulin-heparin infusions peritransplant substantially improve single-donor clinical islet transplant success. Transplantation 2010; 89: 465.
12. Barton FB, Rickels MR, Alejandro R, et al. Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care 2012; 35: 1436.
13. Griffin SM, Alderson D, Farndon JR. Comparison of harvesting methods for islet transplantation. Br J Surg 1986; 73: 712.
14. Kin T, Murdoch TB, Shapiro AM, et al. Estimation of pancreas weight from donor variables. Cell Transplant 2006; 15: 181.
15. The CITR Coordinating Center and Investigators. The Collaberative Islet Transplant Registry 2010 Annual Report. 2011. Available at: www.citregistry.org/reports/reports.htm.
16. Rickels MR, Liu C, Shlansky-Goldberg RD, et al. Improvement in beta-cell secretory capacity after human islet transplantation according to the CIT07 protocol. Diabetes 2013; 62: 2890.
17. Bellin MD, Barton FB, Heitman A, et al. Potent induction immuno-therapy promotes long-term insulin independence after islet transplantation in type 1 diabetes. Am J Transplant 2012; 12: 1576.
18. Piemonti L, Everly MJ, Maffi P, et al. Alloantibody and autoantibody monitoring predicts islet transplantation outcome in human type 1 diabetes. Diabetes 2013; 62: 1656.
19. Pepper AR, Gala-Lopez B, Ziff O, et al. Current status of clinical islet transplantation. World J Transplant 2013; 3: 48.
20. Ryan EA, Paty BW, Senior PA, et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005; 54: 2060.
21. O'Gorman D, Kin T, Pawlick R, et al. Clinical islet isolation outcomes with a highly purified neutral protease for pancreas dissociation. Islets 2013; 5: 111.
22. Kin T, Shapiro AM. Surgical aspects of human islet isolation. Islets 2010; 2: 265.